Page last updated: 2024-08-23

quinapril and Cold Fingers, Hereditary

quinapril has been researched along with Cold Fingers, Hereditary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maddison, P1
Barnes, T; Black, CM; Camilleri, J; Chakravarty, K; Denton, CP; Doré, CJ; Emery, P; Gliddon, AE; Griffiths, B; Herrick, A; Hickling, P; Hopkinson, ND; Lanyon, P; Laversuch, C; Lawson, T; Maddison, PJ; Mallya, R; McHugh, N; Moots, R; Nisar, M; Rhys-Dillon, C; Sheeran, T1

Reviews

1 review(s) available for quinapril and Cold Fingers, Hereditary

ArticleYear
Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition.
    Rheumatology (Oxford, England), 2002, Volume: 41, Issue:9

    Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Protocols; Humans; Isoquinolines; Middle Aged; Multicenter Studies as Topic; Peripheral Vascular Diseases; Quinapril; Randomized Controlled Trials as Topic; Raynaud Disease; Registries; Scleroderma, Localized; Scleroderma, Systemic; Tetrahydroisoquinolines; United Kingdom

2002

Trials

1 trial(s) available for quinapril and Cold Fingers, Hereditary

ArticleYear
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:11

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Quinapril; Raynaud Disease; Scleroderma, Limited; Tetrahydroisoquinolines; Treatment Outcome

2007